跳至主要内容
临床试验/NCT07662083
NCT07662083尚未招募不适用

Randomized Controlled Trial Evaluating Trans Auricular Vagal Nerve Stimulation in Patients With Irritable Bowel Syndrome Constipation Subtype

West Virginia University1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2026年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
80
试验地点
1

研究概览

简要总结

This study evaluates the efficacy and safety of transcutaneous auricular vagus nerve stimulation (ta-VNS) in adults with constipation-predominant irritable bowel syndrome (IBS-C). Participants will be randomized to receive either active or sham stimulation using a non-invasive auricular device over a 60-day period.

The primary objectives are to assess changes in symptom severity and quality of life using validated instruments, including the IBS Symptom Severity Scale (IBS-SSS) and the IBS Quality of Life questionnaire (IBS-QOL). Secondary assessments include safety and participant compliance.

This study aims to determine whether ta-VNS is an effective non-invasive therapeutic modality for improving symptoms and quality of life in patients with IBS-C.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Referred to the WVU Department of Gastroenterology and Hepatology
  • Diagnosis of IBS-C

排除标准

  • Failure of second-line therapy with secretagogues (linaclotide, lubiprostone, plecanatide, or tenapanor)
  • Failure of third-line therapy with tegaserod
  • Known debilitating psychiatric illness
  • Cognitive impairment
  • Pregnancy
  • Prisoners
  • Active substance use disorder
  • Concurrent opioid use
  • History of major gastrointestinal surgery resulting in luminal alteration
  • History of vagotomy
  • Secondary causes of constipation (e.g., opioid use, uncontrolled hypothyroidism, celiac disease)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Zain Sobani

Assistant Professor

West Virginia University

研究点 (1)

Loading locations...

相似试验